Bosh sahifaALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
13,32 $
Seans yopilganidan keyin:(0,00%)0,00
13,32 $
Yopilgan:2-yan, 16:00:47 (GMT-5) · USD · OTCMKTS · Ogohlantirish
Yopilish kursi
13,29 $
Kunlik diapazon
13,25 $ - 13,41 $
Yillik diapazon
8,37 $ - 13,92 $
Bozor kapitalizatsiyasi
3,79 trln JPY
Oʻrtacha hajm
108,56 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (JPY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 524,32 mlrd | 13,37% |
Joriy xarajat | 325,88 mlrd | -4,65% |
Sof foyda | 79,21 mlrd | 120,60% |
Sof foyda marjasi | 15,11 | 94,72% |
Har bir ulushga tushum | — | — |
EBITDA | 140,20 mlrd | 59,23% |
Amaldagi soliq stavkasi | 23,97% | — |
Balans
Jami aktivlari
Jami passivlari
| (JPY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 287,05 mlrd | -2,03% |
Jami aktivlari | 3,45 trln | -0,35% |
Jami passivlari | 1,84 trln | -4,89% |
Umumiy kapital | 1,61 trln | — |
Tarqatilgan aksiyalar | 1,79 mlrd | — |
Narxi/balansdagi bahosi | 0,01 | — |
Aktivlardan daromad | 6,85% | — |
Kapitaldan daromad | 9,83% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (JPY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 79,21 mlrd | 120,60% |
Operatsiyalardan naqd pul | 227,76 mlrd | 251,42% |
Sarmoyadan naqd pul | -13,46 mlrd | 17,87% |
Moliyadan naqd pul | -144,75 mlrd | -166,37% |
Naqd pulning sof oʻzgarishi | 71,66 mlrd | 821,24% |
Boʻsh pul | 195,05 mlrd | 347,45% |
Haqida
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Tashkil etilgan
1-apr, 2005
Bosh ofis
Sayt
Xodimlar soni
13 643
